Septerna, Inc. - SEPN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | President and COO | M | D | 4,000.0 | 0.0 | 0.0 | 84,911.0 | View | |
| Apr 17, 2026 | President and COO | S | D | 326.0 | 25.8623 | 8,431.11 | 174,209.0 | View | |
| Apr 17, 2026 | President and COO | S | D | 1,101.0 | 25.2394 | 27,788.58 | 174,535.0 | View | |
| Apr 17, 2026 | President and COO | S | D | 2,573.0 | 23.7558 | 61,123.67 | 175,636.0 | View | |
| Apr 17, 2026 | President and COO | M | A | 4,000.0 | 6.81 | 27,240.0 | 178,209.0 | View | |
| Mar 04, 2026 | Chief People Officer | M | D | 5,101.0 | 0.0 | 0.0 | 5,101.0 | View | |
| Mar 04, 2026 | Chief People Officer | M | D | 11,638.0 | 0.0 | 0.0 | 3,460.0 | View | |
| Mar 04, 2026 | Chief People Officer | M | D | 53,714.0 | 0.0 | 0.0 | 15,969.0 | View | |
| Mar 04, 2026 | Chief People Officer | S | D | 66,363.0 | 28.1383 | 1,867,342.0 | 793.0 | View | |
| Mar 04, 2026 | Chief People Officer | S | D | 4,090.0 | 27.5052 | 112,496.27 | 67,156.0 | View | |
| Mar 04, 2026 | Chief People Officer | M | A | 5,101.0 | 2.76 | 14,078.76 | 71,246.0 | View | |
| Mar 04, 2026 | Chief People Officer | M | A | 11,638.0 | 2.76 | 32,120.88 | 66,145.0 | View | |
| Mar 04, 2026 | Chief People Officer | M | A | 53,714.0 | 1.55 | 83,256.7 | 54,507.0 | View | |
| Feb 20, 2026 | President and COO | M | D | 4,000.0 | 0.0 | 0.0 | 88,911.0 | View | |
| Feb 20, 2026 | President and COO | S | D | 1,800.0 | 29.5831 | 53,249.58 | 174,209.0 | View | |
| Feb 20, 2026 | President and COO | S | D | 2,200.0 | 28.4594 | 62,610.68 | 176,009.0 | View | |
| Feb 20, 2026 | President and COO | M | A | 4,000.0 | 6.81 | 27,240.0 | 178,209.0 | View | |
| Feb 10, 2026 | SVP, Drug Discovery | A | A | 80,000.0 | 0.0 | 0.0 | 80,000.0 | View | |
| Feb 10, 2026 | SVP, Biological Sciences | A | A | 80,000.0 | 0.0 | 0.0 | 80,000.0 | View | |
| Feb 10, 2026 | Chief People Officer | A | A | 80,000.0 | 0.0 | 0.0 | 80,000.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | A | A | 125,000.0 | 0.0 | 0.0 | 125,000.0 | View | |
| Feb 10, 2026 | Chief Medical Officer | A | A | 125,000.0 | 0.0 | 0.0 | 125,000.0 | View | |
| Feb 10, 2026 | President and COO | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Feb 10, 2026 | Chief Executive Officer | A | A | 400,000.0 | 0.0 | 0.0 | 400,000.0 | View | |
| Feb 10, 2026 | Chief Legal Officer | A | A | 165,000.0 | 0.0 | 0.0 | 165,000.0 | View | |
| Nov 13, 2025 | SVP, Drug Discovery | S | D | 3,501.0 | 18.0586 | 63,223.16 | 92,911.0 | View |